TCM
TCG Crossover Management’s Tyra Biosciences TYRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Hold |
2,898,103
| – | – | 3.17% | 15 |
|
|
2025
Q1 | $27M | Buy |
2,898,103
+909,000
| +46% | +$8.45M | 3.68% | 10 |
|
|
2024
Q4 | $27.6M | Hold |
1,989,103
| – | – | 2.7% | 16 |
|
|
2024
Q3 | $46.8M | Hold |
1,989,103
| – | – | 3.96% | 10 |
|
|
2024
Q2 | $31.8M | Hold |
1,989,103
| – | – | 3.31% | 12 |
|
|
2024
Q1 | $32.6M | Hold |
1,989,103
| – | – | 2.58% | 17 |
|
|
2023
Q4 | $27.5M | Hold |
1,989,103
| – | – | 3.06% | 15 |
|
|
2023
Q3 | $27.4M | Hold |
1,989,103
| – | – | 4.03% | 13 |
|
|
2023
Q2 | $33.9M | Hold |
1,989,103
| – | – | 5.56% | 8 |
|
|
2023
Q1 | $32M | Hold |
1,989,103
| – | – | 6.23% | 5 |
|
|
2022
Q4 | $15.1M | Buy |
1,989,103
+1,043,396
| +110% | +$7.93M | 2.67% | 15 |
|
|
2022
Q3 | $8.31M | Buy |
945,707
+49,289
| +5% | +$433K | 2.49% | 13 |
|
|
2022
Q2 | $6.41M | Hold |
896,418
| – | – | 2.72% | 12 |
|
|
2022
Q1 | $9.59M | Buy |
896,418
+45,968
| +5% | +$492K | 3.85% | 9 |
|
|
2021
Q4 | $12M | Buy |
+850,450
| New | +$12M | 5.6% | 8 |
|